Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Pre- and early postoperative GFAP serum levels in glioma and brain metastases.

Baumgarten P, Quick-Weller J, Gessler F, Wagner M, Tichy J, Forster MT, Foerch C, Seifert V, Mittelbronn M, Senft C.

J Neurooncol. 2018 May 24. doi: 10.1007/s11060-018-2898-1. [Epub ahead of print]

PMID:
29797180
2.

Comment: Carotid artery stenting: Is the gut making the decision?

Foerch C.

Neurology. 2018 Apr 10;90(15):681. doi: 10.1212/WNL.0000000000005293. Epub 2018 Mar 14. No abstract available.

PMID:
29540585
3.

Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke.

De Marchis GM, Schneider J, Weck A, Fluri F, Fladt J, Foerch C, Mueller B, Luft A, Christ-Crain M, Arnold M, Katan M.

Neurology. 2018 Feb 6;90(6):e455-e465. doi: 10.1212/WNL.0000000000004922. Epub 2018 Jan 10.

PMID:
29321236
4.

Early Screening Parameters for Dysphagia in Acute Ischemic Stroke.

Henke C, Foerch C, Lapa S.

Cerebrovasc Dis. 2017;44(5-6):285-290. doi: 10.1159/000480123. Epub 2017 Sep 14.

5.

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis.

Stolz L, Derouiche A, Devraj K, Weber F, Brunkhorst R, Foerch C.

J Neuroinflammation. 2017 Jul 28;14(1):152. doi: 10.1186/s12974-017-0926-2.

6.

Serum concentrations of glial fibrillary acidic protein (GFAP) do not indicate tumor recurrence in patients with glioblastoma.

Vietheer JM, Rieger J, Wagner M, Senft C, Tichy J, Foerch C.

J Neurooncol. 2017 Oct;135(1):193-199. doi: 10.1007/s11060-017-2565-y. Epub 2017 Jul 17.

PMID:
28717884
7.

A Proposal for a Patient-Oriented Five-Dimensional Approach for Surveillance and Therapy in Multiple Sclerosis.

Yalachkov Y, Foerch C, Wahl M, Gehrig J.

Front Neurol. 2017 Jul 3;8:313. doi: 10.3389/fneur.2017.00313. eCollection 2017. No abstract available.

8.

Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis.

Schmitz K, Brunkhorst R, de Bruin N, Mayer CA, Häussler A, Ferreiros N, Schiffmann S, Parnham MJ, Tunaru S, Chun J, Offermanns S, Foerch C, Scholich K, Vogt J, Wicker S, Lötsch J, Geisslinger G, Tegeder I.

Acta Neuropathol Commun. 2017 Jun 2;5(1):42. doi: 10.1186/s40478-017-0446-4.

9.

Predictors of Dysphagia in Acute Pontine Infarction.

Lapa S, Luger S, Pfeilschifter W, Henke C, Wagner M, Foerch C.

Stroke. 2017 May;48(5):1397-1399. doi: 10.1161/STROKEAHA.116.015045. Epub 2017 Apr 11.

10.

[Direct oral anticoagulants and acute stroke : Insights into translational research studies].

Foerch C, Schäfer JH, Pfeilschifter W, Bohmann F.

Nervenarzt. 2017 Jun;88(6):642-651. doi: 10.1007/s00115-017-0282-6. Review. German.

PMID:
28188404
11.

12/15-Lipoxygenase Inhibition or Knockout Reduces Warfarin-Associated Hemorrhagic Transformation After Experimental Stroke.

Liu Y, Zheng Y, Karatas H, Wang X, Foerch C, Lo EH, van Leyen K.

Stroke. 2017 Feb;48(2):445-451. doi: 10.1161/STROKEAHA.116.014790. Epub 2017 Jan 5.

12.

Elevated Serum Glial Fibrillary Acidic Protein (GFAP) is Associated with Poor Functional Outcome After Cardiopulmonary Resuscitation.

Helwig K, Seeger F, Hölschermann H, Lischke V, Gerriets T, Niessner M, Foerch C.

Neurocrit Care. 2017 Aug;27(1):68-74. doi: 10.1007/s12028-016-0371-6.

PMID:
28054291
13.

Glial Fibrillary Acidic Protein Serum Levels Distinguish between Intracerebral Hemorrhage and Cerebral Ischemia in the Early Phase of Stroke.

Luger S, Witsch J, Dietz A, Hamann GF, Minnerup J, Schneider H, Sitzer M, Wartenberg KE, Niessner M, Foerch C; BE FAST II and the IGNITE Study Groups.

Clin Chem. 2017 Jan;63(1):377-385. doi: 10.1373/clinchem.2016.263335. Epub 2016 Nov 23.

14.

Endovascular Treatment of a Severe Stroke Occurring in a Commercial Airplane Over the Sahara.

Foerch C, Mayer CA, Berkefeld J, You SJ.

Aerosp Med Hum Perform. 2016 Sep;87(9):825-9. doi: 10.3357/AMHP.4515.2016.

PMID:
27634705
15.

Estimating the Quantitative Demand of NOAC Antidote Doses on Stroke Units.

Pfeilschifter W, Farahmand D, Niemann D, Ikenberg B, Hohmann C, Abruscato M, Thonke S, Strzelczyk A, Hedtmann G, Neumann-Haefelin T, Kollmar R, Singer OC, Ferbert A, Steiner T, Steinmetz H, Reihs A, Misselwitz B, Foerch C.

Cerebrovasc Dis. 2016;42(5-6):415-420. Epub 2016 Jul 21.

PMID:
27438461
16.

Risk of long-term anticoagulation under sustained severe arterial hypertension: A translational study comparing warfarin and the new oral anticoagulant apixaban.

Pfeilschifter W, Steinstraesser T, Paulus P, Zeiner PS, Bohmann F, Theisen A, Lindhoff-Last E, Penski C, Wagner M, Mittelbronn M, Foerch C.

J Cereb Blood Flow Metab. 2017 Mar;37(3):855-865. doi: 10.1177/0271678X16642443. Epub 2016 Jul 20.

17.

Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling.

Gurnik S, Devraj K, Macas J, Yamaji M, Starke J, Scholz A, Sommer K, Di Tacchio M, Vutukuri R, Beck H, Mittelbronn M, Foerch C, Pfeilschifter W, Liebner S, Peters KG, Plate KH, Reiss Y.

Acta Neuropathol. 2016 May;131(5):753-73. doi: 10.1007/s00401-016-1551-3. Epub 2016 Mar 1.

18.

Treatment with FTY720 has no beneficial effects on short-term outcome in an experimental model of intracerebral hemorrhage.

Schlunk F, Pfeilschifter W, Yigitkanli K, Lo EH, Foerch C.

Exp Transl Stroke Med. 2016 Feb 18;8:1. doi: 10.1186/s13231-016-0016-z. eCollection 2016.

19.

Adherence to oral anticoagulant therapy in secondary stroke prevention - impact of the novel oral anticoagulants.

Luger S, Hohmann C, Niemann D, Kraft P, Gunreben I, Neumann-Haefelin T, Kleinschnitz C, Steinmetz H, Foerch C, Pfeilschifter W.

Patient Prefer Adherence. 2015 Nov 23;9:1695-705. doi: 10.2147/PPA.S88994. eCollection 2015.

20.

Alpha-methylacyl-CoA racemase deletion has mutually counteracting effects on T-cell responses, associated with unchanged course of EAE.

Tafferner N, Barthelmes J, Eberle M, Ulshöfer T, Henke M, deBruin N, Mayer CA, Foerch C, Geisslinger G, Parnham MJ, Schiffmann S.

Eur J Immunol. 2016 Mar;46(3):570-81. doi: 10.1002/eji.201545782. Epub 2016 Jan 22.

21.

Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine.

Brunkhorst R, Friedlaender F, Ferreirós N, Schwalm S, Koch A, Grammatikos G, Toennes S, Foerch C, Pfeilschifter J, Pfeilschifter W.

Neural Plast. 2015;2015:503079. doi: 10.1155/2015/503079. Epub 2015 Oct 28.

22.

Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma.

Tichy J, Spechtmeyer S, Mittelbronn M, Hattingen E, Rieger J, Senft C, Foerch C.

J Neurooncol. 2016 Jan;126(2):361-9. doi: 10.1007/s11060-015-1978-8. Epub 2015 Oct 30.

PMID:
26518540
23.

Awaken, You Arteries and Limbs!

Foerch C, Hennerici MG.

Cerebrovasc Dis. 2015;40(5-6):301-3. doi: 10.1159/000441284. Epub 2015 Oct 29. No abstract available.

24.

Quantifying the Benefit of Prehospital Rapid Treatment in Acute Stroke: Benchmark for Future Innovative Clinical Trials.

Lorenz MW, Lauer A, Foerch C.

Stroke. 2015 Nov;46(11):3168-76. doi: 10.1161/STROKEAHA.115.010445. Epub 2015 Oct 6.

25.

Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.

Eberle M, Ebel P, Mayer CA, Barthelmes J, Tafferner N, Ferreiros N, Ulshöfer T, Henke M, Foerch C, de Bazo AM, Grösch S, Geisslinger G, Willecke K, Schiffmann S.

Immunol Cell Biol. 2015 Oct;93(9):825-36. doi: 10.1038/icb.2015.47. Epub 2015 Apr 2.

PMID:
25833068
26.

[Pseudomigraine with cerebrospinal fluid pleocytosis : Alice in Wonderland syndrome].

Zeiner PS, Steinmetz H, Foerch C.

Nervenarzt. 2015 Jun;86(6):751-2. doi: 10.1007/s00115-015-4286-9. German. No abstract available.

PMID:
25791803
27.

Lack of ceramide synthase 2 suppresses the development of experimental autoimmune encephalomyelitis by impairing the migratory capacity of neutrophils.

Barthelmes J, de Bazo AM, Pewzner-Jung Y, Schmitz K, Mayer CA, Foerch C, Eberle M, Tafferner N, Ferreirós N, Henke M, Geisslinger G, Futerman AH, Grösch S, Schiffmann S.

Brain Behav Immun. 2015 May;46:280-92. doi: 10.1016/j.bbi.2015.02.010. Epub 2015 Feb 16.

PMID:
25697397
28.

Organists and organ music composers.

Foerch C, Hennerici MG.

Prog Brain Res. 2015;216:331-41. doi: 10.1016/bs.pbr.2014.11.032. Epub 2015 Jan 20. Review.

PMID:
25684298
29.

Gaps and hurdles deter against following stroke guidelines for thrombolytic therapy in Iran: exploring the problem.

Nikkhah K, Avan A, Shoeibi A, Azarpazhooh A, Ghandehari K, Foerch C, Saposnik G, Sasannejad P, Vakili V, Layegh P, Farzadfard MT, Bavarsad Shahripour R, Hosseini MR, Azarpazhooh MR.

J Stroke Cerebrovasc Dis. 2015 Feb;24(2):408-15. doi: 10.1016/j.jstrokecerebrovasdis.2014.09.012. Epub 2014 Dec 12.

PMID:
25511616
30.

Warfarin pretreatment reduces cell death and MMP-9 activity in experimental intracerebral hemorrhage.

Schlunk F, Schulz E, Lauer A, Yigitkanli K, Pfeilschifter W, Steinmetz H, Lo EH, Foerch C.

Transl Stroke Res. 2015 Apr;6(2):133-9. doi: 10.1007/s12975-014-0377-3. Epub 2014 Nov 27.

PMID:
25424451
31.

Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.

De Marchis GM, Weck A, Audebert H, Benik S, Foerch C, Buhl D, Schuetz P, Jung S, Seiler M, Morgenthaler NG, Mattle HP, Mueller B, Christ-Crain M, Arnold M, Katan M.

Stroke. 2014 Oct;45(10):2918-23. doi: 10.1161/STROKEAHA.114.005584. Epub 2014 Aug 28.

32.

[Glial fibrillary acidic protein in patients with symptoms of acute stroke: diagnostic marker of cerebral hemorrhage].

Foerch C, Pfeilschifter W, Zeiner P, Brunkhorst R.

Nervenarzt. 2014 Aug;85(8):982-9. doi: 10.1007/s00115-014-4128-1. Review. German.

PMID:
25057113
33.

Prescription frequency and predictors for the use of novel direct oral anticoagulants for secondary stroke prevention in the first year after their marketing in Europe--a multicentric evaluation.

Luger S, Hohmann C, Kraft P, Halmer R, Gunreben I, Neumann-Haefelin T, Kleinschnitz C, Walter S, Haripyan V, Steinmetz H, Foerch C, Pfeilschifter W.

Int J Stroke. 2014 Jul;9(5):569-75. doi: 10.1111/ijs.12289. Epub 2014 May 15.

PMID:
24828272
34.

Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation.

Schaefer JH, Leung W, Wu L, Van Cott EM, Lok J, Whalen M, van Leyen K, Lauer A, van Ryn J, Lo EH, Foerch C.

J Cereb Blood Flow Metab. 2014 May;34(5):870-5. doi: 10.1038/jcbfm.2014.31. Epub 2014 Feb 19.

35.

Coadministration of FTY720 and rt-PA in an experimental model of large hemispheric stroke-no influence on functional outcome and blood-brain barrier disruption.

Cai A, Schlunk F, Bohmann F, Kashefiolasl S, Brunkhorst R, Foerch C, Pfeilschifter W.

Exp Transl Stroke Med. 2013 Oct 28;5(1):11. doi: 10.1186/2040-7378-5-11.

36.

Decoding the iceman's death?

Foerch C.

Cell Mol Life Sci. 2014 Feb;71(3):539-40. doi: 10.1007/s00018-013-1536-5. Epub 2013 Dec 11. No abstract available.

PMID:
24327101
37.

Predicting stroke mortality: BNP could it be?

Jickling GC, Foerch C.

Neurology. 2013 Dec 3;81(23):1970-1. doi: 10.1212/01.wnl.0000436949.75473.79. Epub 2013 Nov 1.

PMID:
24186914
38.

The gap between trial data and clinical practice -- an analysis of case reports on bleeding complications occurring under dabigatran and rivaroxaban anticoagulation.

Pfeilschifter W, Luger S, Brunkhorst R, Lindhoff-Last E, Foerch C.

Cerebrovasc Dis. 2013;36(2):115-9. doi: 10.1159/000352062. Epub 2013 Sep 11.

PMID:
24029592
39.

FTY720 treatment in the convalescence period improves functional recovery and reduces reactive astrogliosis in photothrombotic stroke.

Brunkhorst R, Kanaan N, Koch A, Ferreirós N, Mirceska A, Zeiner P, Mittelbronn M, Derouiche A, Steinmetz H, Foerch C, Pfeilschifter J, Pfeilschifter W.

PLoS One. 2013 Jul 31;8(7):e70124. doi: 10.1371/journal.pone.0070124. Print 2013.

40.

Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography.

Won SY, Schlunk F, Dinkel J, Karatas H, Leung W, Hayakawa K, Lauer A, Steinmetz H, Lo EH, Foerch C, Gupta R.

Stroke. 2013 Oct;44(10):2883-90. doi: 10.1161/STROKEAHA.113.001224. Epub 2013 Aug 6.

41.

Exploring gender distribution in patients with acute stroke: A multi-national approach.

Foerch C, Ghandehari K, Xu G, Kaul S.

J Res Med Sci. 2013 Jan;18(1):10-6.

42.

Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator.

Pfeilschifter W, Kashefiolasl S, Lauer A, Steinmetz H, Foerch C.

Neuroscience. 2013 Oct 10;250:181-8. doi: 10.1016/j.neuroscience.2013.07.003. Epub 2013 Jul 13.

PMID:
23856067
43.

Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment.

Diener HC, Foerch C, Riess H, Röther J, Schroth G, Weber R.

Lancet Neurol. 2013 Jul;12(7):677-88. doi: 10.1016/S1474-4422(13)70101-7. Epub 2013 May 31. Review.

PMID:
23726849
44.

Brain stem infarction associated with familial Mediterranean fever and central nervous system vasculitis.

Luger S, Harter PN, Mittelbronn M, Wagner M, Foerch C.

Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):93-5. Epub 2013 May 27.

PMID:
23710607
45.

Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases.

Mayer CA, Brunkhorst R, Niessner M, Pfeilschifter W, Steinmetz H, Foerch C.

PLoS One. 2013 Apr 23;8(4):e62101. doi: 10.1371/journal.pone.0062101. Print 2013.

46.

Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies.

Lauer A, Pfeilschifter W, Schaffer CB, Lo EH, Foerch C.

Lancet Neurol. 2013 Apr;12(4):394-405. doi: 10.1016/S1474-4422(13)70049-8. Epub 2013 Mar 18. Review.

47.

Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study.

De Marchis GM, Katan M, Weck A, Fluri F, Foerch C, Findling O, Schuetz P, Buhl D, El-Koussy M, Gensicke H, Seiler M, Morgenthaler N, Mattle HP, Mueller B, Christ-Crain M, Arnold M.

Neurology. 2013 Apr 2;80(14):1278-86. doi: 10.1212/WNL.0b013e3182887944. Epub 2013 Mar 6.

PMID:
23468541
48.

Intravenous tPA therapy does not worsen acute intracerebral hemorrhage in mice.

Foerch C, Rosidi NL, Schlunk F, Lauer A, Cianchetti FA, Mandeville E, Arai K, Yigitkanli K, Fan X, Wang X, van Leyen K, Steinmetz H, Schaffer CB, Lo EH.

PLoS One. 2013;8(2):e54203. doi: 10.1371/journal.pone.0054203. Epub 2013 Feb 8.

49.

Intracranial hypotension as an important differential diagnosis of deep brain swelling: a case report.

Bothe AM, Berkefeld J, Singer OC, Foerch C, Hattingen E.

Clin Neuroradiol. 2014 Mar;24(1):65-8. doi: 10.1007/s00062-013-0202-5. Epub 2013 Feb 8. No abstract available.

PMID:
23392580
50.

Graphite furnace atomic absorption spectrophotometry--a novel method to quantify blood volume in experimental models of intracerebral hemorrhage.

Kashefiolasl S, Foerch C, Pfeilschifter W.

J Neurosci Methods. 2013 Feb 15;213(1):147-50. doi: 10.1016/j.jneumeth.2012.10.022. Epub 2012 Nov 9.

PMID:
23147006

Supplemental Content

Loading ...
Support Center